Volume 20, Number 12—December 2014
CME ACTIVITY - Research
Bacterial Pathogens Associated with Hidradenitis Suppurativa, France
Table 2
Characteristics | Profile A | Profile B | No profile | Negative culture | p value* |
---|---|---|---|---|---|
Sex | 0.2 | ||||
M, n = 35 | 5 | 24 | 3 | 3 | |
F, n = 67 |
19 |
41 |
1 |
6 |
|
Clinical severity of lesions† | 2 × 10–11 | ||||
Hurley stage 1, n = 38 | 22 | 9 | 2 | 5 | |
Hurley stage 2, n = 45 | 2 | 40 | 0 | 3 | |
Hurley stage 3, n = 19 |
0 |
16 |
2 |
1 |
|
Topography of lesions | 0.01 | ||||
Inguinal fold, n = 32 | 5 | 24 | 1 | 2 | |
Buttock and thigh, n = 19 | 8 | 6 | 1 | 4 | |
Gluteal fold, n = 13 | 2 | 10 | 0 | 1 | |
Trunk, n = 4 | 1 | 2 | 1 | 0 | |
Breast, n = 6 | 4 | 2 | 0 | 0 | |
Axilla, n = 28 | 4 | 21 | 1 | 2 |
*By Fisher exact test comparing the repartitions of profiles A and B.
†Hurley staging: Hurley, stage 1 lesions correspond to nodules or abscesses, single or multiple, without sinus tracts or hypertrophic scars. Stage 2 lesions are single or multiple but nonconfluent lesions with sinus tracts and formation of scarring. Stage 3 lesions correspond to diffuse or nearly diffuse involvement of multiple interconnected sinus tracts or abscesses across the entire area.
Page created: November 18, 2014
Page updated: November 18, 2014
Page reviewed: November 18, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.